Noxxon Pharma
Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.
Total raised
€35M
€35,000,000
Funding rounds
2
Investors
0
distinct backers
Active since
2010-04
latest 2010-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood10
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-10-01 | Other | €2.0M | — | View deal → |
| 2010-05-01 | Other | €33M | — | View deal → |